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Background:Several studies using echocardiography identified epicardial adipose tissue (EPI) as an important
cardiometabolic risk marker. However, validation compared with magnetic resonance imaging (MRI) or com-
puted tomography has not been performed. Moreover, pericardial adipose tissue (PERI) has recently been
shown to have some correlation with cardiovascular disease risk factors. The aims of this study were to val-
idate echocardiographic analyses compared with MRI and to evaluate which cardiac fat depot (EPI or PERI) is
the most appropriate cardiovascular risk marker.Methods: Forty-nine healthy subjects were studied (age range, 25–68 years; body mass index, 21–40 kg/m2),
and PERI and EPI fat depots were measured using echocardiography and MRI. Findings were correlated with
MRI visceral fat and subcutaneous fat, blood pressure, insulin sensitivity, triglycerides, cholesterol, insulin,
glucose, and 10-year coronary heart disease risk.Results:Most cardiac fat was constituted by PERI (about 77%). PERI thickness by echocardiography was well
correlated with MRI area (r = 0.36, P = .009), and independently of the technique used for quantification, PERI
was correlated with body mass index, waist circumference, visceral fat, subcutaneous fat, blood pressure, in-
sulin sensitivity, triglycerides, cholesterol, glucose, and coronary heart disease risk. On the contrary, EPI thick-
nesses correlated only with age did not correlate significantly with MRI EPI areas, which were found to
correlate with age, body mass index, subcutaneous fat, and hip and waist circumferences.Conclusions: Increased cardiac fat in the pericardial area is strongly associated with features of the metabolic
syndrome, whereas no correlation was found with EPI, indicating that in clinical practice, PERI is a better car-
diometabolic risk marker than EPI. (J Am Soc Echocardiogr 2011;-:---.)
Keywords: MRI, Echocardiography, Epicardial, Mediastinal and visceral fatSeveral studies have shown that increased accumulation of fat around
the heart is associated with an increased risk for cardiovascular disease
and metabolic disease.1-5 Cardiac fat can be distinguished in two
depots: (1) epicardial adipose tissue (EPI), the fat concentrated in the
atrioventricular and interventricular grooves, along the major
branches of the coronary arteries and, to a lesser extent, around the
atria, over the free wall of the right ventricle and over the apex of the
left ventricle, and (2) pericardial adipose tissue (PERI), the fat
situated on the external surface of the parietal pericardium within
themediastinum (alternatively termedmediastinal or intrathoracic fat).
Both EPI and PERI have been found to be strongly associated with
obesity, preferential visceral fat accumulation, and hypertension.2,5-9onal Research Council Institute of Clinical Physiology, Pisa, Italy.
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echo.2011.06.013In human hearts randomly collected from diagnostic autopsies, EPI
was associated with body mass index (BMI), but it was not related
to either hypertension or ischemia.10 Recently, the 1H magnetic reso-
nance spectroscopic technique has been used to study the intracellu-
lar lipid content of cardiomyocytes.11 Visceral fat deposition has been
recognized as an important risk factor for cardiovascular diseases2,9
and is correlated with insulin resistance,12,13 cardiovascular risk
factors,12,14 and the metabolic syndrome.12
Several techniques, including echocardiography, computed to-
mography (CT), and magnetic resonance imaging (MRI), have been
used to quantify fat deposition around the heart.2,5,8,15,16 However,
most published studies have used ultrasound and measured EPI
thickness.9,12,14,17,18 Recently, it has been demonstrated that EPI
thickness $ 5 mm measured by ultrasound may identify an
individual with a higher likelihood of having detectable carotid
atherosclerosis.19 More expensive imaging techniques such as MRI
and CT have the advantage of measuring fat area and/or volume
and quantifying separately EPI, PERI, and total cardiac adipose
tissue,2 but these methods can be expensive and time consuming
and, in the case of CT, expose patients to radiation. Ultrasound
may be an appealing alternative to these imaging techniques because
of its wide availability, low cost, and lack of radiation exposure. The
aim of this study was to assess agreement between MRI (area) and1
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- 2011ultrasound (thickness) for the
measurement of EPI and PERI
and its correlation with meta-
bolic parameters.METHODS
Subjects
The patient population under in-
vestigation was a subset of sub-
jects who participated in
previously published studies,7,20
selected according to the
following criteria: (1) absence of
diabetes at enrollment, (2) BMI
< 40 kg/m2, (3) absence ofmetabolic or nonmetabolic diseases (except essential hypertension),
and (4) no treatment with drugs known to affect glucose tolerance.
A subset of subjects enrolled for the metabolic study also agreed to
undergo complete rest echocardiography. Thus, the final group was
composed of 49 subjects (38 men, 11 women). The study protocol
was approved by the institutional review board of the University of
Pisa, and each subject gave written informed consent at the time of
enrollment.Study Design
Subjects underwent (1) measurement of global cardiac function and
regional left ventricular function by MRI and echocardiography, (2)
quantitation of abdominal subcutaneous and visceral fat and EPI con-
tent by MRI, and (3) quantitation of PERI and EPI by echocardiogra-
phy or MRI (see below). An individual 10-year coronary heart disease
(CHD) risk was estimated using the Framingham Heart Study predic-
tion score sheet.21Anthropometrics Measurements
Weight (to the nearest 0.1 kg) and height (to the nearest 0.5 cm) were
measured while the subjects were fasting and wearing only their un-
dergarments. BMI was calculated as body weight divided by height
squared andwas used as amarker of obesity degree. The ratio of waist
circumference to hip circumference was determined by measuring
the waist circumference at the narrowest part of the torso and the
hip circumference in a horizontal plane at the level of the maximal ex-
tension of the buttocks.MRI
Abdominal visceral fat and subcutaneous fat depots were measured
by MRI, using imaging procedures that have been published previ-
ously.5 Briefly, images were acquired on a GE Signa Excite HD
1.5-T scanner (GE Medical Systems, Milwaukee, WI; slew rate, maxi-
mum 150 T/m/sec) that operates with a 50 mT/m gradient using
a body coil. A sagittal localizing image was used to center transverse
sections on the line through the space between L4 and L5. Thirty-
two transverse, T1-weighted 256  256 images (repetition time,
135 msec; echo time, 4.2 msec; flip angle, 90; field of view,
50 cm; pixel size, 1.875 1.875 mm) were acquired during a breath
hold with a slice thickness of 5 mm and no overlap. Data were trans-
ferred to a dedicated workstation and analyzed using software devel-
oped ad hoc22 to determine abdominal subcutaneous and visceral fatareas and volumes. Subcutaneous fat area was analyzed by automatic
detection of the outer and inner margins of subcutaneous adipose
tissue as a region of interest from the cross-sectional images and by
counting the number of pixels between the outer and inner margins
of subcutaneous adipose tissue. Visceral (intra-abdominal) fat area
was determined using histograms specific to the visceral regions.
The histograms were summed over the range of pixel values desig-
nated as fat by fitting two normal analysis distribution curves to
them. A factor of 0.92 was used to convert adipose tissue volume
into adipose tissue mass.5
MRI acquisition of the heart involved a standardized protocol. A
cardiac coil and electrocardiographic triggering were used for the se-
quences; during the acquisition time, patients were in breath hold
(10–12 sec). Cardiac adipose tissue scans were obtained by fast
spin-echo T1-weighted sequences with oblique axial orientation, for
a correct study of horizontal long axes of the heart in diastole23
(echo time, 42 msec; echo train length, 23 msec; bandwidth,
62.50 KHz; slice thickness, 8 mm; slice gap, 0 mm; field of view,
28.5 cm;matrix size, 288224; number of signals acquired, 1; trigger
delay, minimum; 8-mm-thick section, 0-mm intersection gap, field of
view, and a 256 256 matrix). EPI was defined as any adipose tissue
located within the pericardial sac.5,8 PERI and EPI areas were
measured using an in-house semiautomatic program to determinate
the margin of fat around the heart, identifying region of interest and
measuring the number of pixels, as previously described.5
Echocardiography
Each subject underwent transthoracic two-dimensional echocardiog-
raphy according to the recommendations of the European
Association of Echocardiography24 (Vivid 7; GE Vingmed
Ultrasound AS, Horten, Norway), with an M3S matrix-array trans-
ducer. Echocardiography was performed using standard techniques
with subjects in the left lateral decubitus position. Depth was adjusted
as the aortic and mitral valves were positioned lowest on the screen.
The adipose fat depot was measured on the free wall of the right ven-
tricle from both parasternal long-axis and short-axis views at end-
diastole in three cardiac cycles. The maximum value at any site was
measured, and the average value was considered.25 EPI was defined
as an echolucent space between the linear echodense parietal pericar-
dium and the right ventricular epicardium, and PERI was defined as
an echolucent area above the parietal pericardium. EPI and PERI
were measured on the still images of the two-dimensional echocar-
diogram obtained at end-diastole on both parasternal long-axis and
short-axis views, as described previously.9 Echocardiograms were pre-
liminarily read by a first reader and subsequently reread by a highly
experienced reader. Both readers were blinded to subjects’ anthropo-
metric features. The coefficient of variation between the two different
echocardiographers was 4%, indicating good reproducibility of the
echocardiographic measurements.Statistical Analysis
Data are expressed as mean6 SEM. Data with a skewed distribution
(plasma triglyceride, cholesterol, and insulin concentrations) are
expressed as medians and interquartile ranges and were log-
transformed for use in statistical analysis. The two methods (echocar-
diography andMRI) were compared using Bland Altman plots. Given
the different units (millimeters vs square millimeters), we normalized
the data to the total cardiac fat, calculated as the sum of either extra-
PERI and PERI thickness (millimeters) or area (square millimeters). In
this way, both methods gave values ranging from 0 and 1.
Table 1 Clinical characteristics of the population
Variable Value
Men/women 38/11
NGT/IGT/T2DM 34/13/1
Age (y) 48 6 1 (25–68)
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check index and using the oral glucose insulin sensitivity index, which
equals the average metabolic clearance rate of glucose during the oral
glucose tolerance test and has been validated against the euglycemic
insulin clamp technique.26 Ten-year CHD risk was calculated using
the Framingham score.21 Correlations were calculated using
Spearman’s coefficient.BMI (kg/m ) 28.8 6 0.5 (21–40)
Waist circumference (cm) 97 6 2 (68–125)
Hip circumference (cm) 105 6 1 (80–138)
Waist-to-hip ratio 0.92 6 0.10 (0.72–1.09)
Echocardiographic EPI
thickness (mm)
3.1 6 0.3 (0.5–8.5)
Echocardiographic PERI
thickness (mm)
4.7 6 0.3 (1–10)
MRI EPI area (mm2) 827 6 54 (172–2,008)
MRI PERI area (mm2) 1,813 6 128 (100–4,014)
2RESULTS
Clinical, echocardiographic, and MRI characteristics of the study pop-
ulation are reported in Table 1. As shown in the table, in this group of
subjects with a wide range of BMIs, most cardiac fat was constituted
by PERI (77%). In Figure 1, we report two sample cases acquired with
MRI and echocardiography.MRI TCAT area (mm ) 264 6 152 (467–5,007)
SC (kg) 3.5 6 0.2 (1.1–8.3)
VF (kg) 1.3 6 0.1 (0.1–2.6)
VF/SC ratio 0.39 6 0.3 (0.06–0.86)
Triglyceride (mmol/L) 0.9 (0.8) (0.3–4.0)
Cholesterol (mmol/L) 5.1 (0.9) (2.1–7.6)
HDL cholesterol (mmol/L) 1.2 (0.3) (0.7–2.4)
Systolic blood pressure (mm Hg) 131 6 2 (100–181)
Diastolic blood pressure (mm Hg) 77 6 2 (46–102)Concordance in the Assessment of Cardiac Fat
A good correlation was found between the PERI measurements ob-
tained with the two techniques, but not for EPI (Figure 2). On
Bland-Altman analysis, when the EPI and PERI values were normal-
ized to total fat, the agreement between the two techniques was
good, with a nonsignificant trend toward overestimation of EPI and
underestimation of PERI with echocardiography (Figure 2).Glucose (mmol/L) 5.5 6 0.1 (4.6–8.2)
Insulin (pmol/L) 72 (45) (16–237)
QUICKI 0.142 6 0.002 (0.119–0.183)
10-year CHD risk 7.7 6 0.8 (2–25)
HDL, High-density lipoprotein; IGT, impaired glucose tolerance;
NGT, normal glucose tolerance;QUICKI, quantitative insulin sensitiv-
ity check index; SC, subcutaneous fat; TCAT, total cardiac adipose
tissue; T2DM, type 2 diabetes mellitus; VF, visceral fat.
Data are expressed as numbers, mean6 SEM, or median (interquar-
tile range).The Relationship Between Cardiac Fat and Metabolic
Parameters
As shown in Table 2, PERI, but not EPI, measured with both tech-
niques was correlated with the parameters of metabolic syndrome
such as triglyceride and glucose concentrations, blood pressure, insu-
lin sensitivity, and BMI. PERI thickness on echocardiography showed
a strong correlation with 10-year CHD Framingham risk score,
whereas no correlation was found with epicardial risk score (Table 2).The Relationship Between Cardiac Fat and Visceral Fat
Visceral and abdominal subcutaneous fat volumes were measured
using MRI. Both techniques showed a positive association be-
tween visceral fat and PERI, but no correlation with EPI depots
(Figures 3 and 4). Subcutaneous fat volumes were significantly
correlated with both EPI and PERI measured on MRI but not
echocardiography. Again, this difference may be accounted for
the parameters measured, area versus thickness.DISCUSSION
In obese patients, PERI was strongly correlated with the metabolic
syndrome, whereas no correlation was found with EPI. In particular,
PERI was associated with cardiovascular risk factors, increased vis-
ceral fat accumulation, blood pressure, glucose tolerance, lipid con-
centrations, insulin resistance, and 10-year CHD risk calculated
using the Framingham score. Moreover, when comparing ultrasound
and cardiac magnetic resonance (CMR) for the detection of total fat
and the relative contribution of EPI and PERI, the two techniques pro-
vided comparable results. Our results suggest a prevalent role of PERI
compared with EPI related to the metabolic syndrome and cardiovas-
cular risk factors in a wide range of obese healthy volunteers. To our
knowledge, no report exists on the comparison of ultrasound andCMR for the assessment of cardiac fat and its relation to metabolic
syndrome.Comparison With Previous Studies
Several clinical studies have shown the relationship of echocardio-
graphic EPI thickness and risk factors. EPI thickness in subjects with
the metabolic syndrome is significantly higher than that observed in
subjects without the metabolic syndrome.12 EPI thickness is inversely
associated with insulin sensitivity, as assessed by euglycemic hyperin-
sulinemia clamp studies in obese subjects.13 Moreover, EPI is inde-
pendently associated with fasting glucose, low-density lipoprotein
cholesterol, and blood pressure.27 Our results are consistent with
these previous results. Although in humans, cardiac fat has been eval-
uated mainly using ultrasonography, measuring EPI thickness, CMR
and CTare able to quantify volumes of cardiac fat and distinguish be-
tween EPI and PERI. A recent review showed that the association be-
tween metabolic parameters and visceral fat was stronger with total
rather than epicardial cardiac fat.2 In the Framingham Heart Study,
PERI measured by CTwas correlated with multiple measures of adi-
posity and cardiovascular disease risk factors. In a large cohort of sub-
jects, PERI measured by CT was found to be predictive of incident
CHD independent of conventional risk factors.8 In a previous study
from our group, which measured both PERI and EPI, only PERI
area, not EPI, was correlated with visceral fat.5 Cardiac fat is deposited
Figure 1 (Top) Four-chamber view of the heart of a subject with low total cardiac fat (left) and a subject with high total cardiac fat
(right). (Bottom) Transthoracic long-axis view of the heart of a subject with cardiac (intra-abdominal and PERI) fat (left) and cardiac
fat (right).
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- 2011both strictly around the myocardium (EPI) but also in the intratho-
racic space (PERI or mediastinal fat) and has been found strongly
associated with obesity and increased visceral fat.2,6-9,25
Pathophysiologic Implications
In the present study, we measured two different layers of fat, EPI and
PERI. There are several reasons to distinguish between these two
types of fat with regard to embryonic origin, distribution, function,
and vascularization. PERI originates from the primitive thoracic mes-
enchyme, and it is supplied by noncoronary sources, whereas EPI
shares the same microcirculation as the myocardium.25,27,28
However, under normal conditions, PERI is 20% to 50% of the
heart mass, whereas EPI represents approximately 20%. Therefore,
they are two different cardiac visceral fat depots. Few studies have
addressed the potential different behavior of the two depots. In
fact, reports from both the Framingham Heart Study and the Multi-
Ethnic Study of Atherosclerosis do not seem to distinguish between
these two depots when discussing their biomolecular properties,8,29
defining PERI as any adipose tissue located within the pericardial
sac. Hence, some authors prefer to define PERI as paracardial fat.30The physiologic, biochemical, and biomolecular properties of EPI
with its potential interrelation with the myocardium are better char-
acterized than those of PERI, and more studies are needed to explore
these differences, if any. The present study provides new insights on
PERI (or paracardial fat) and its potential role as a biomarker of risk in
obese patients. The reason why, in this study population, the two fat
depots behaved differently is a matter of speculation. However, both
techniques, ultrasound and CMR, when blindly used provided the
same results, with good agreement. Transthoracic echocardiography
can be accurately used for the quantitation of cardiac fat, but the
quantitation of only EPI is often difficult, highly dependent on the
acoustic window and on the operator’s experience. Compared
with CT, echocardiography is free of ionizing radiation, which is an
increasingly important issue from the patient and social perspec-
tives,31,32 especially in cardiology patients exposed to high
cumulative radiation doses from noninvasive testing.33 However,
only with MRI or CT is it possible to quantify the area of cardiac ad-
ipose tissue, distinguishing between EPI and extra-PERI, as well as
avoiding pericardial fluids (sometimes present even in normal cardiac
conditions).
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Figure 2 (Left) Relationship between fat thickness measured by echocardiography and fat measured by MRI. (Right) Bland-Altman
plots for the differences between theMRI and echocardiographic data expressed as percentage of total cardiac fat (PERI plus EPI) to
compare the two measurements.
Table 2 Matrix of correlations
Variable Echocardiographic EPI Echocardiographic PERI MRI EPI MRI PERI MRI TCAT
BMI NS 0.37 (.008) 0.38 (.006) 0.44 (.001) 0.51 (.0001)
Age 0.32 (.02) 0.52 (<.0001) 0.29 (.04) NS NS
Triglyceride NS 0.33 (.02) NS 0.55 (.0001) 0.47 (.0006)
Cholesterol NS NS NS 0.35 (.02) 0.29 (.04)
HDL cholesterol NS NS NS NS NS
VF NS 0.32 (.03) NS 0.56 (<.0001) 0.54 (<.0001)
SC NS NS 0.39 (.006) 0.28 (.05) 0.37 (.009)
Systolic blood pressure NS 0.37 (.009) NS 0.35 (.01) 0.31 (.3)
Diastolic blood pressure NS 0.41 (.003) NS 0.31 (.3) 0.32 (.3)
Glucose NS 0.49 (.003) NS 0.27 (.06) 0.29 (.05)
Insulin NS NS NS NS NS
QUICKI NS 0.30 (.04) NS 0.26 (.08) 0.26 (.08)
Waist circumference NS NS 0.34 (.02) 0.51 (.0002) 0.56 (.0001)
Hip circumference NS NS 0.32 (.3) 0.37 (.01) 0.43 (.003)
10-year CHD risk NS 0.51 (.0001) NS 0.35 (.01) 0.34 (.02)
HDL, High-density lipoprotein; QUICKI, quantitative insulin sensitivity check index; SC, subcutaneous fat; TCAT, total cardiac adipose tissue;
VF, visceral fat.
Data are expressed as correlation coefficient (P value).
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There were several limitations to be acknowledged in the present
study. Two different techniques were directly compared by looking
at the contribution of EPI and PERI to total fat (i.e., the ratios EPI/
[EPI + PERI] and PERI/[EPI + PERI]), because the two methods
give very different measurements (thickness vs area). The Bland-
Altman plots showed good agreement between MRI and echocar-diography, although a nonsignificant trend toward overestimation
of EPI and underestimation of PERI using echocardiography was
observed. Moreover, echocardiographic fat thickness assessment
has in general higher variability than area measured with MRI,
even though highly trained echocardiographers were involved,
and all were trained by the same operator, who reviewed all the
exams. There is no consensus on methodology for fat assessment,
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- 2011but most studies have measured it in end-systole. During diastole,
the fat is compressed, so it is best measured at end-systole at the
point on the free wall of the right ventricle, at which the ultra-
sound beam is oriented in a perpendicular manner, with the aortic
annulus as a landmark. Conversely, it has been suggested that de-
formity of EPI also exists during systole and that EPI should be
measured in diastole. Because no consensus exists on how to mea-
sure cardiac fat with ultrasound, to be consistent with MRI, we
measured fat in diastole. Moreover, echocardiography is highly af-
fected by the acoustic window, which may be suboptimal in obese
patients. Still, the parasternal views may be accessible in these
patients.
The sample size was small, and no definitive conclusions can
be drawn, but the patient population under investigation had
unique features: all patients were obese in different stages of
severity, and all had a thorough metabolic characterization.
Moreover, we were able to compare a high-technology imaging
technique with a more accessible, low-cost, and readily available
one, showing the potential relevant clinical implications of such
an approach.CONCLUSIONS
Imaging of cardiac fat has relevant implications for the assessment of
risk in several subsets of patients.2,6,10,12 Our results demonstrate that
MRI and ultrasound are comparable for the assessment of adipose
tissue, with differences strictly related to technology characteristics:
MRI was more accurate and operator independent than
echocardiography and not limited by the acoustic window, but with
threefold higher cost, lower availability, and longer imaging and
analysis times. PERI is significantly related to the metabolic
syndrome, more so than EPI, but the relation between cardiac fat
depots and metabolism is still elusive, and more studies on several
subsets of patients are warranted. Moreover, which technique and
which parameter (i.e., EPI vs PERI or rather increased deposition fat
around the heart) is best to be translated into clinical practice have
yet to be determined.ACKNOWLEDGMENTS
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